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Protein phosphorylation regulates a large variety of biological processes in
all living cells. In pathogenic bacteria, the study of serine, threonine, and tyr-
osine (Ser/Thr/Tyr) phosphorylation has shed light on the course of infectious
diseases, from adherence to host cells to pathogen virulence, replication, and
persistence. Mass spectrometry (MS)-based phosphoproteomics has provided
global maps of Ser/Thr/Tyr phosphosites in bacterial pathogens. Despite
recent developments, a quantitative and dynamic view of phosphorylation
events that occur during bacterial pathogenesis is currently lacking. Tempo-
ral, spatial, and subpopulation resolution of phosphorylation data is required
to identify key regulatory nodes underlying bacterial pathogenesis. Herein,
we discuss how technological improvements in sample handling, MS instru-
mentation, data processing, and machine learning should improve bacterial
phosphoproteomic datasets and the information extracted from them. Such
information is expected to significantly extend the current knowledge of Ser/
Thr/Tyr phosphorylation in pathogenic bacteria and should ultimately con-
tribute to the design of novel strategies to combat bacterial infections.
Keywords: antibiotic kinase inhibitors; antibiotic resistance; BY-kinases;
Hanks kinases; host–pathogen interactions; machine learning; omics
integration; pathogenic bacteria; phosphoproteomics; Ser/Thr/Tyr
phosphorylation
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lar weight; MRSA, methicillin-resistant S. aureus; MS, mass spectrometry; PASTA, penicillin binding protein and Ser/Thr kinase-associated;
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Protein phosphorylation on serine (Ser), threonine
(Thr), and tyrosine (Tyr) residues dynamically regu-
lates the cellular activities in bacteria, archaea, and
eukarya. By modulating the conformation and macro-
molecular interactions of proteins, phosphate attach-
ment can change the activity, stability, or localization
of proteins to guide cellular signaling. Although most
thoroughly studied in eukarya, where it is the most
common type of post-translational modification
(PTM) [1], Ser/Thr/Tyr phosphorylation is increasingly
recognized for playing wide-ranging and essential roles
in the control of bacterial life, including the process of
pathogenesis [2–5]. Other phosphorylation systems in
bacteria include the phosphorylation of histidines and
aspartates [such as in two-component systems (TCSs)]
and, less commonly, of arginines and cysteines, with
considerable crosstalk occurring between the different
modification systems [6]. The phosphorylation reaction
is catalyzed by distinct types of residue-specific kinases
and is reversed by cognate phosphatases to terminate
signaling events. Most bacterial Ser/Thr-specific
kinases belong to the evolutionary conserved Hanks-
type family, which are also present in eukaryotes [7–9].
In addition, bacteria contain a small group of atypical
Ser/Thr kinases [10,11]. Most Tyr-directed kinases in
bacteria do not, in contrast to eukarya, belong to the
Hanks family, but are bacteria-specific and referred to
as bacterial tyrosine kinases (BY-kinases) [10,12,13].
The catalytic domain of BY-kinases is characterized by
the presence of Walker A, A’ and B ATP/GTP-bind-
ing motifs [12,13]. All BY-kinases, as well as many
Hanks kinases, are transmembrane or membrane-asso-
ciated proteins that can relay signals from the extracel-
lular environment to the cell interior [9,12,13]. Many
Hanks kinases contain repeats of so-called penicillin
binding protein and Ser/Thr kinase-associated
(PASTA) domains in their extracellular portion that
bind cell wall fragments [14,15]. Table 1 provides an
overview of Ser/Thr- and Tyr-specific kinases identified
in a selection of commonly studied pathogenic bacteria
mentioned in this review [9,11,13,16–19]. Compara-
tively, much less is known about bacterial phos-
phatases, which are also fewer in number. The ones
described to date include the phosphoprotein and
metal-dependent phosphatases (PPPs and PPMs) act-
ing on Ser/Thr residues, and the conventional and low
molecular weight (LMW) protein Tyr-specific phos-
phatases (PTPs) [9,20]. Notably, there are also exam-
ples of kinases and phosphatases displaying dual
amino acid specificity [5,21–23]. Detailed descriptions
of bacterial kinases and phosphatases and their modes
of regulation can be found in other reviews
[9,10,12,13,24].
Bacterial pathogens are defined as any type of bacte-
ria able to cause infection in a host organism. The
infection process follows a sequence of events includ-
ing pathogen host entry, immune evasion, replication,
dissemination, and persistence. Literature on how bac-
terial Ser/Thr/Tyr phosphorylation is implicated in
each of these steps is accumulating. We therefore start
this review by presenting a selection of these functional
studies. The current rise in antibiotic drug resistance
poses an ever-increasing threat to human health and
urgently calls for new therapeutic opportunities. As
future therapies may involve targeted inhibition of the
pathogenic signaling networks that sustain bacterial
survival in the human host, research aiming at obtain-
ing in-depth knowledge of bacterial phosphorylation
systems should be prioritized. However, we are still far
from having a complete picture of how phosphoryla-
tion networks contribute to pathogenesis. Mass spec-
trometry (MS)-based phosphoproteomics has become
a key technology for obtaining global and systematic
views of phosphorylation networks in biological sys-
tems. This review therefore places particular focus on
the use of phosphoproteomics in the study of patho-
genic bacteria. We provide a comprehensive overview
of phosphoproteomic studies that have recorded phos-
phorylation sites at a global scale in different types of
pathogens and describe the use of phosphoproteomics
to understand kinase–substrate relationships and host–
Major take-home messages from this review
• Serine, threonine, and tyrosine (Ser/Thr/Tyr)
phosphorylation plays wide-ranging roles in bac-
terial pathogens affecting both basic physiology
and pathogen-specific processes.
• Recent advances in bacterial phosphoproteomics
have significantly increased our insight into the
width of pathogen Ser/Thr/Tyr phosphorylation
substrates.
• Further improvements in sample preparation, MS
instrumentation, and data acquisition and analy-
sis should enable time-resolved and spatially
resolved analyses of both bacterial and host cell
phosphoproteomes during in vivo infections.
• Automated methods to predict the functional
implications of bacterial phosphosites should be
developed.
• Omics integration and machine-learning methods
will help to obtain a systems-level understanding
of the phosphorylation networks driving bacterial
pathogenesis.
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pathogen interactions. Successively, a discussion on
current and future technical advancements that should
move the field forward with the ultimate goal of
obtaining deep and quantitative views of the phospho-
rylation networks supporting bacterial infections is
provided. Furthermore, based on insights obtained
from eukaryal phosphorylation, we describe how pro-
tein structural and evolutionary information can facili-
tate qualified predictions of phosphosite functions. We
then generally outline how machine learning can help
reveal regulatory patterns embedded in complex phos-
phoproteomic datasets, and how ‘omics’ data integra-
tion should allow for a systems-level analysis of
infectious disease. Finally, we discuss how knowledge
of protein phosphorylation can be exploited in the
design of new antibacterial therapies.
Control of bacterial pathogenesis by
Ser/Thr/Tyr phosphorylation
It is becoming increasingly clear that protein phospho-
rylation has the potential to regulate most types of cel-
lular processes, and hence, it is not surprising that
phosphorylation also acts as an important regulator in
the context of pathogenesis. To this attest, it has been
shown for diverse types of pathogens that inactivation
of specific kinases reduces or attenuates their virulence
in animal models [14,25–33]. Kinase-dependent in vivo
virulence has, for example, been well documented for
species of Streptococci using different infection models.
In Streptococcus agalactiae (group B streptococci),
mutation of the PASTA-domain-containing Hanks
kinase Stk1 diminishes virulence in a neonatal rat
model of sepsis [29], and mutation of the homologous
kinase of Streptococcus pneumoniae, StkP, decreases
the bacterial burden in the lungs and blood of intrana-
sally or intravenously infected mice [30]. Furthermore,
in Streptococcus pyogenes (group A streptococci) Stk1
has been found essential for disease development in a
mouse myositis model of infection [31]. Kinase inacti-
vation has also been seen to reduce the initial coloniza-
tion of intestinal pathogens [19,34]. As shown in a
hamster infection model, deletion of the Hanks kinase
PrkC of Clostridium difficile leads to a delay in gut col-
onization, although it has no significant effect on over-
all virulence [34]. In some cases, kinase-mediated
virulence may depend on the bacterial strain or the
infection model. While deletion of the Staphylococ-
cus aureus Stk1 Hanks kinase (also known as PknB) in
the SH100 strain background causes a significant
reduction of virulence in a mouse model of
pyelonephritis [32], deletion of Stk1 in the Newman
strain has no effect in a septicemia disease model [35].
What is more, a methicillin-resistant S. aureus (MRSA)
USA300 Dstk1 strain was actually seen to cause a more
severe infection in a cutaneous mouse model compared
to the USA300 wild-type strain [36]. Consistent with
the dynamic nature of phosphorylation being impor-
tant for cell function, phosphatase abrogation also fre-
quently affects in vivo infection outcomes [22,35,37–39].
This includes the secreted LMW PtpA Tyr phosphatase
of S. aureus, which enhances bacterial survival within
macrophages and promotes mouse liver infectivity [38].
Similarly, the also secretory LMW but dual-specificity
phosphatase SP-PTP of S. pyogenes is required for nor-
mal adherence to human lung cells and in vivo viru-
lence in mice. Consistently, SP-PTP overexpression
causes hypervirulence [22].
Table 1. Table listing reported Ser/Thr and Tyr kinases identified in a selection of commonly studied pathogenic bacteria. Additional
uncharacterized kinases are likely to exist in some of these species. ND, no data.
Bacterium Ser/Thr kinases Tyr kinases References
Mycobacterium tuberculosis PknA; PknB; PknD; PknE; PknF;
PknG; PknH; PknI; PknJ; PknK; PknL
PtkA [9,13]
Streptococcus pneumoniae StkP CpsD; Ubk (only
an autokinase?)
[9,13,16]
Staphylococcus aureus Stk1 (PknB) CapB [9,13,32]
Mycoplasma pneumoniae PrkC ND [9]
Listeria monocytogenes PrkA ND [9]
Escherichia coli HipA; YeaG; YihE (SrkA); Stk Etk; Wzc [8,9,11,13,17]
Yersinia spp. YpkA (YopO) ND [9]
Pseudomonas aeruginosa PpkA WaaP [9,13,26]
Salmonella typhimurium SteC; RdoA PutA [11,13,162]
Klebsiella pneumoniae KpnK Wzc [13,18]
Enterococcus faecalis IreK (PrkC) ND [19]
Clostridium difficile PrkC; CD2148 ND [34]
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The above-mentioned studies clearly demonstrate
the importance of Ser/Thr/Tyr kinases and phos-
phatases for bacterial virulence. Yet the specific mech-
anisms by which these enzymes contribute to
pathogenicity remain to be systematically elucidated.
Individual kinases and phosphatases generally have
multiple protein substrates operating in different cellu-
lar pathways. Thus, phosphorylation-based regulation
is exerted on many levels of pathogen function and
must be understood in a context- and species-specific
manner. The literature on phosphorylation in the regu-
lation of bacterial physiology and pathogenicity is vast
and it is beyond the scope of this review to cover cur-
rent knowledge in an all-encompassing manner. In this
section, we nonetheless seek to illustrate the diversity
by which Ser/Thr/Tyr phosphorylation can influence
bacterial infections via the control of some critical
pathogen functions.
Pathogen cell division and cell wall biosynthesis
Most bacteria harbor a peptidoglycan-based cell wall,
which acts to protect the bacterium from lysis in its
differing environments. Both cell elongation and the
septum formed during cell division require peptidogly-
can synthesis, making cell wall growth and division
highly interlinked processes. Protein phosphorylation,
especially by membrane-associated Hanks-type kinases
with PASTA repeats, plays significant roles in regulat-
ing these processes. For instance, the Hanks kinase
StkP is a key regulator of cell division in S. pneumo-
niae and controls the balance between elongated cell
growth and septation [40]. In an stkP mutant, cell wall
synthesis is perturbed resulting in elongated cells [40–
42]. During cell division, StkP, together with its cog-
nate phosphatase PhpP, localizes to the septum and
regulates a number of cell division proteins [40]. One
of these is DivIVA, and DivIVA phosphorylation neg-
atively regulates cell elongation and promotes cell divi-
sion [41,43]. StkP can also regulate cell division at the
direct level of cell wall peptidoglycan synthesis. At the
division site, the peptidoglycan synthase PBP2a forms
a complex with the membrane-anchored cofactor
MacP. MacP is in turn phosphorylated by StkP, lead-
ing to PBP2a activation [44]. A recent study aimed at
dissecting the roles of the StkP PASTA repeats during
S. pneumoniae cell division showed that while the three
membrane-proximal repeats are required for kinase
activation and septal cell wall thickness, the mem-
brane-distal repeat ensures proper localization of StkP
at the division site and effective cell separation [45].
Interestingly, StkP activation was seen not to depend
on PASTA peptidoglycan binding and thus contrasts
the generally accepted view of PASTA-dependent
kinase activation [9,45].
The S. aureus Stk1 Hanks kinase is also involved in
the regulation of cell wall metabolism and division
[32]. The cell wall precursor molecule Lipid II has been
reported as the activating signal for Stk1, and binding
to lipidII variants induces Stk1 autophosphorylation
in vitro [46]. In vivo, Stk1 localizes to the septum fol-
lowing recruitment of the contractile Z-ring forming
protein FtsZ. Phosphorylation reduces FtsZ GTPase
activity to possibly modulate Z-ring dynamics. In addi-
tion, Stk1 phosphorylates the response regulator
WalR, which controls the expression of a number of
proteins involved in cell wall remodeling [46].
In Mycobacterium tuberculosis, we also find a
PASTA-domain-containing Hanks kinase, PknB,
involved in regulating cell wall metabolism. Here, a
key PknB substrate is the peptidoglycan synthase
CwlM [47,48]. In its phosphorylated form, CwlM
interacts with the forkhead-associated (FHA)-domain
protein FhaA in the cytosol to presumably control
peptidoglycan synthesis. Conversely, nonphosphory-
lated CwlM localizes to the cell membrane and inter-
acts with the lipid flippase MurJ important for
peptidoglycan precursor export (Fig. 1A) [48]. Interest-
ingly, in the related, but mostly nonpathogenic
Mycobacterium smegmatis, phosphorylation of CwlM
quickly diminishes when cells are starved, suggesting
that CwlM phosphorylation acts to adjust peptidogly-
can synthesis according to nutrient status [47].
Virulence gene expression
Pathogens produce a variety of virulence factors that
enable them to colonize host cells and tissues and sur-
vive inside their host. Kinase or phosphatase inactiva-
tion often significantly alters bacterial gene expression
profiles, including expression levels of virulence deter-
minants [31,36,37,39,49–51]. These phenotypes are due
to both direct and indirect effects of kinases and phos-
phatases on gene transcription. Inactivation of kinases
or phosphatases may affect the transcription of genes
regulated by direct kinase/phosphatase targets, but
potentially also, indirectly, of genes part of the same
gene regulatory networks. A common way by which
phosphorylation directly regulates virulence gene
expression is by modulating the DNA-binding proper-
ties of transcriptional regulators [52]. This is the case
for the highly conserved catabolite control protein and
virulence regulator CcpA in S. aureus. CcpA gets
phosphorylated on two threonine residues in its DNA-
binding domain by Stk1. By abrogating CcpA DNA
binding, this phosphorylation event prevents the
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Fig. 1. Schematic illustrations of protein phosphorylation in the control of pathogen life cycle processes such a cell wall biosynthesis (A),
virulence gene expression (B), host signaling interference (C) and host persistence (D). (A) Mycobacterium tuberculosis cell wall synthesis is
controlled by the Hanks-type PASTA kinase PknB via phosphorylation of the peptidoglycan synthase CwlM. Left: Nonphosphorylated CwlM
is localized at the cell membrane where it interacts with the lipid flippase MurJ, responsible for transporting peptidoglycan precursors
across the membrane. Right: An accumulation of un-cross-linked extracellular peptidoglycan is sensed by the PknB PASTA repeats and
leads to PknB activation. PknB in turn phosphorylates CwlM as well as MurJ, stimulating their interaction with the FHA-domain protein
FhaA implicated in peptidoglycan biosynthesis [48]. (B) Staphylococcus aureus Stk1 regulates the expression of virulence genes via the
phosphorylation of transcriptional regulators. Left: Stk1-mediated phosphorylation of the catabolite control protein CcpA within its DNA-
binding domain prevents CcpA binding to its target DNA sequence and expression of the cytotoxic a-hemolysin protein (encoded by the hla
gene) [53]. Right: Stk1 also phosphorylates the stage V sporulation protein SpoVG, which acts as a transcriptional regulator of virulence
genes such as capA, lip, and nuc1. SpoVG gets phosphorylated on four N-terminal threonines, and in contrast to the situation for CcpA,
SpoVG phosphorylation stimulates DNA promoter binding and hence virulence gene expression [54]. (C) A secreted Yersinia Hanks kinase
obstructs host cell signaling. Yersinia bacteria secrete the kinase YpkA into host macrophage cells via its T3SS. Once inside, YpkA is able to
phosphorylate host proteins such as the heterotrimeric Gaq protein and the VASP. Gaq is a G-protein-coupled receptor subunit and is
phosphorylated by YpkA within its highly conserved diphosphate binding domain. This phosphorylation event inhibits Gaq GTP binding and
consequently Gaq signaling functions such as actin cytoskeleton regulation [84]. Similarly, YpkA-mediated phosphorylation of VASP prevents
VASP-driven actin polymerization. These effects on cytoskeleton dynamics impair effective macrophage phagocytosis [85]. (D) The HipA
kinase promotes Escherichia coli host persistence via the glutamyl-tRNA synthetase GltX. When HipA is inactive, GltX exists in a
nonphosphorylated and active state to promote protein translation. However, GltX phosphorylation by active HipA inhibits GltX catalytic
activity, leading to an accumulation of uncharged tRNAGlu, ribosome stalling, and ultimately, cell growth inhibition [109].
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expression of the critical virulence protein a-hemolysin,
a cytotoxin able to induce host cell death [53]. In con-
trast, Stk1-mediated phosphorylation of another S. au-
reus transcriptional regulator, SpoVG, enhances
SpoVG binding to target promoters of virulence genes
such as lip (lipase), nuc1 (thermonuclease 1), and capA
(capsular polysaccharide (CPS) biosynthesis protein;
Fig. 1B) [54]. Exemplifying crosstalk between different
phosphorylation-dependent signaling systems, S. au-
reus Stk1 is also seen to regulate the TCS response
regulator GraR implicated in virulence and antibiotic
resistance [55]. GraR phosphorylation increases its
DNA-binding activity to proposedly induce expression
of genes involved in the modulation of cell wall charge
via wall teichoic acid (WTA) D-alanine incorporation.
This is believed to have a global effect on S. aureus
pathogenicity since WTA charge is important for
diverse processes such as cell growth, host infection
and attachment, biofilm development, and drug resis-
tance [55]. Similar phosphorylation system crosstalk is
seen in Streptococci between the CovR/CovS (control
of virulence) TCS and the Stk1 Hanks kinase. In
S. agalactiae and in S. pyogenes, the CovR transcrip-
tional regulator can be phosphorylated on Thr65 by
Stk1 [39,56,57]. CovR acts mainly as a repressor of
virulence genes, and phosphorylation of CovR on
Asp53 stimulates its DNA binding. On the other hand,
a phospho-mimetic CovR-Thr65Glu variant reduces
Asp53 phosphorylation and consequently CovR pro-
moter regulation [56,57]. Consistently, in S. pyogenes,
the phospho-silenced CovR-Asp53Ala and the phos-
pho-mimetic CovR-Thr65Glu strains were seen to dis-
play similar profiles of gene repression to a CovR-
deleted strain. Interestingly, compared to DcovR,
CovR-Asp53Ala- and CovR-Thr65Glu-expressing
strains were still able to positively influence the expres-
sion of some CovR-activated virulence genes, and in
accordance caused hypervirulence in a mouse infection
model [57]. Similarly, in vivo hypervirulence as well as
increased blood–brain barrier penetration is seen for
S. agalactiae CovR-Asp53Ala-, CovR-Thr65Glu-, and
CovR-deleted strains [58]. Mechanistic insight into
Hanks kinase and TCS crosstalk relevant to bacterial
pathogenicity was also recently provided for S. pneu-
moniae [59]. During host invasion, S. pneumoniae has
to adapt to local fluctuations in pH in both extra- and
intracellular compartments. In response to acidic
stress, S. pneumoniae may undergo acidic stress-in-
duced lysis (ASIL), where virulence factors such as
pneumolysin are released and cause tissue damage [60].
The response regulator ComE controls whether pro-
survival or lytic responses are initiated at low pH
[59,61]. More specifically, Pi~nas et al. demonstrated
that ComE phosphorylation on Thr128 by the StkP
Hanks kinase stimulates ComE DNA binding, induc-
tion of genes involved in H2O2 production and cell
lysis [59]. In contrast, StkP-deleted and ComE-
Thr128Ala mutant strains were blocked in ASIL and
displayed increased survival in pneumocytes [59].
Finally, an example of transcription factor regula-
tion via Tyr phosphorylation has been elucidated in
enterohemorrhagic Escherichia coli (EHEC). Tyr phos-
phorylation of the sugar-sensing transcription regula-
tor Cra reduces its DNA binding and leads to
downregulation of type III secretion system (T3SS)
expression under glycolytic conditions, a condition
where T3SS is usually not needed [62]. Recent phos-
phoproteomic studies have identified multiple tran-
scriptional and post-transcriptional regulators
phosphorylated on tyrosine residues in species such as
E. coli and Shigella flexneri [63,64], and future charac-
terization of these sites should allow us to uncover
how Tyr phosphorylation affects virulence gene expres-
sion.
Regulation of pathogen exopolysaccharides
Besides governing virulence gene expression, Ser/Thr/
Tyr phosphorylation regulates pathogen host invasion
and survival through multiple other means. These
include the regulation of cell surface capsular and non-
capsular exopolysaccharides to facilitate host adher-
ence, biofilm formation, immune system avoidance,
and antibiotic resistance. Particularly, BY-kinases are
recognized for their role in exopolysaccharide produc-
tion and export [12,13]. A well-studied example is the
Wzc BY-kinase of E. coli, which acts together with its
cognate phosphatase Wzb in the synthesis of group 1
capsular and colonic acid polysaccharides [65–67]. The
current model proposes that the cycling of Wzc
autophosphorylation and Wzb-mediated dephosphory-
lation drives proper exopolysaccharide assembly [67].
Although the exact mechanism by which this influ-
ences exopolysaccharide production is not known,
crystallographic studies suggest that Wzc phosphoryla-
tion and dephosphorylation cause Wzc to exist in
mono- and oligomeric states, respectively [68]. Simi-
larly, the other E. coli BY-kinase–phosphatase pair
Etk–Etp promotes group 4 capsule formation in enter-
opathogenic strains [69]. In addition, Wzc and Etk can
both phosphorylate the same tyrosine residue on the
UDP-glucose dehydrogenase Ugd involved in the syn-
thesis of exopolysaccharide precursors [70,71]. Whereas
Ugd phosphorylation by Wzc regulates colanic acid
production, Ugd phosphorylation by Etk is important
for resistance to the antibiotic polymyxin [71]. In the
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context of CPS synthesis, crosstalk between Tyr and
Ser/Thr phosphorylation has interestingly been seen to
coordinate capsular and cell wall synthesis in S. aureus
by regulating the distribution of precursor molecules
common to the two pathways [72]. While the
CapA1B1 BY-kinase complex activates CPS synthesis
via phosphorylation of the biosynthetic enzymes CapO
[73], CapE, and CapM, the Ser/Thr kinase Stk1 pro-
motes peptidoglycan synthesis and reduces CPS pro-
duction by inhibiting CapA1B1 kinase and CapM
glycosyltransferase activities [72]. BY-kinases are also
able to coordinate capsule formation with cell division
[74]. In S. pneumoniae, autophosphorylation of the
BY-kinase CpsD, which forms part of a larger CPS
assembly complex, is required for proper capsule pro-
duction at the septum. Furthermore, by modulating
the mobility of the chromosome partitioning protein
ParB, phosphorylated CpsD acts to coordinate cell
constriction with the encapsulation of daughter cells
[74].
Host establishment
Upon infection with bacterial pathogens, the host initi-
ates a variety of cellular signaling events that act to
stimulate innate and adaptive immune defense mecha-
nisms and ultimately restrict pathogen dissemination.
A key virulence strategy utilized by pathogens to sub-
vert these processes and thus promote their own sur-
vival is the injection of effector molecules into host
cells. Effector translocation is mediated via specialized
secretion systems and these are frequently regulated by
phosphorylation. Initially, the reciprocal activity of the
PpkA–PppA Thr kinase/phosphatase pair was seen to
control secretion from a type VI secretion system
(T6SS) in Pseudomonas aeruginosa [75]. In the oppor-
tunistic pathogen Vibrio alginolyticus, T6SSs are con-
trolled by the PpkA2 Hanks kinase. Besides direct
T6SS regulation, PpkA2 controls T6SS expression via
a regulatory circuit involving the quorum sensing sys-
tem [76]. T3SSs are also subjected to diverse modes of
Ser/Thr/Tyr phospho-regulation. During infection,
enterohemorrhagic E. coli uses T3SS both for host
attachment and for injection of effector molecules [77].
In addition to transcriptional regulation, as mentioned
above [62], EHEC T3SS is regulated by the multicargo
chaperone CesT. CesT contains two highly conserved
tyrosine phosphorylation sites and these mediate dif-
ferential effector secretion [78]. In the closely related
S. flexneri, Tyr phosphorylation seems to be a negative
modulator of virulence and a Tyr-phospho-mimetic
mutant of the T3SS-associated ATPase Spa47 displays
impaired effector protein discharge [64].
Secreted effector molecules promote in vivo survival
and propagation by manipulating host signaling and
immune defense mechanisms. Many bacterial effectors
are actually kinases and phosphatases that target host
proteins [23,79–85]. In particular, there are several
examples of secreted bacterial kinases and phos-
phatases disrupting host cytoskeleton structures and
immunity [38,82,83,86,87]. Within the Yersinia genus,
for example, secreted Hanks kinase YpkA (YopO),
disrupts cytoskeleton dynamics via phosphorylation of
host heterotrimeric Gaq protein [82,84] and vasodila-
tor-stimulated phosphoprotein (VASP) [85], obstruct-
ing effective macrophage phagocytosis (Fig. 1C). In
M. tuberculosis, the secreted Tyr-specific PtkA kinase
and PtpA phosphatase, which are encoded in the same
operon, are both required for macrophage intracellular
growth [83,88,89]. Inside macrophages, PtpA dephos-
phorylates and inactivates the host vacuolar protein
sorting-associated protein 33B (VPS33B). This in turn
blocks the trafficking of the vacuolar-H+-ATPase to
the mycobacterial phagosome, impeding phagosome
acidification, phagosome–lysosome fusion, and ulti-
mately bacterial elimination [90]. The molecular mech-
anism behind PtkA-dependent M. tuberculosis
macrophage survival is less understood but may occur
via PtpA, as PtkA-mediated phosphorylation of PtpA
enhances PtpA phosphatase activity [91]. In addition,
PtkA is seen to downregulate the macrophage b-galac-
toside binding protein Galectin 3 involved in regulat-
ing apoptosis, and macrophages infected with a DptkA
strain undergo decreased apoptosis compared to a
wild-type M. tuberculosis strain [89]. The secreted
phosphatase PtpA of S. aureus is also required for
intramacrophage survival, as well as for mouse infec-
tivity, possibly via its interaction with the human
cytoskeleton-associated protein coronin-A [38]. Strep-
tococcus pyogenes encodes two secretory phosphatases,
that is, the Ser/Thr phosphatase SP-STP and the Ser/
Thr and Tyr dual-specificity phosphatase SP-PTP,
which have both been seen to induce virulence in
mouse peritonitis infection models [22,39]. In addition,
both are upregulated upon human pharyngeal cell
internalization [92]. SP-STP induces pharyngeal cell
apoptosis through both extrinsic and intrinsic host cell
stimulation in a manner dependent on its phosphatase
activity. In accordance, a SP-STP knockout strain
induces less host cell apoptosis in the lungs of infected
mice. This suggests that SP-STP interferes with multi-
ple host signaling pathways, and human pharyngeal
cells exposed to ectopically expressed SP-STP display
altered levels of various pro- and anti-apoptotic pro-
teins as well as deregulated histone phosphorylation
[92]. Lastly, to be mentioned is the interference of
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bacterial effectors with host innate immune responses
via the NF-jB pathway. In Legionella pneumophila,
the LegK1 Hanks kinase is secreted via the Dot/Icm
type IV secretion system into host macrophages where
it activates the NF-jB pathway by functionally mim-
icking host IjB kinase (IKK) proteins [93].
In some other cases, bacterial pathogens secrete pro-
teins that upon becoming phosphorylated by a host
kinase can suppress or hijack host protein function
[94–96]. More specifically, Tyr-phosphorylated bacte-
rial effectors can recruit a diverse array of host pro-
teins containing pTyr-binding Src homology 2 (SH2)
domains and thereby disrupt diverse host processes
[97]. Moreover, bacterial SH2 domains were recently
identified in a large group of Legionella effector pro-
teins. These were shown to bind Tyr-phosphorylated
host proteins with high affinity, proposing a novel
mechanism by which bacteria can interfere with host
cell signaling [98].
Finally, phosphorylation can guide the metabolic
adaptation of pathogens to their changing host envi-
ronment. Detailed mechanistic insight has been
obtained for the regulation of glutamate metabolism
by the soluble mycobacterial Hanks kinase PknG
[27,99–101]. Curiously, PknG phosphorylation of
GarA induces an intramolecular association in GarA
between its phosphorylated N terminus and its pThr-
binding FHA domain, which acts as a switch to relieve
the inhibitory interaction with the a-ketoglutarate
decarboxylase and NAD+-specific glutamate dehydro-
genase [99,100]. PknG activation depends on nutrient
status [102]. More precisely, periplasm amino acid
levels are sensed by the solute binding protein GlnH
and the signal is transmitted via the transmembrane
protein GlnX to cytosolic PknG [101].
Pathogen persistence
In case of chronic disease, bacteria can employ differ-
ent mechanisms for persistence, of which some are
based on protein phosphorylation. Biofilm formation
is a well-known strategy for development of persistent
infection [103]. Biofilms involve the production of an
extracellular matrix that consists of a mixture of pro-
teins, lipids, DNA, and different exopolysaccharides.
As described above, exopolysaccharide production is
regulated by phosphorylation in various ways.
Interestingly, in the dental pathogen Porphy-
romonas gingivalis, the BY-kinase Ptk1 and the metal-
dependent tyrosine phosphatase Php1 are required for
extracellular polysaccharide synthesis as well as for
interspecies community formation with the crucial oral
biofilm constituent Streptococcus gordonii [104,105].
Dual-species assemblies are facilitated by the binding
of the P. gingivalis fimbrial adhesion protein Mfa1 to
the S. gordonii surface SspA/B proteins, and Ptk1
induces Mfa1 expression by suppressing transcription
of the negative gene regulator CdhR [104], possibly
via direct CdhR phosphorylation [106]. Ptk1 is itself a
substrate for both Php1 and of the LMW tyrosine
phosphatase Ltp1, with the latter having a positive
effect on CdhR levels and a restrictive impact on
P. gingivalis–S. gordonii community development
[107,108]. Another important element of persistence is
cell dormancy where the stochastic establishment of
subpopulations of nonreplicating bacteria can confer
resistance to antibiotics targeting proliferating cells.
Upon drug withdrawal, reservoirs of dormant cells
can resume normal growth and re-initiate infections.
In E. coli, phosphorylation can induce the persistence
phenotype via the toxin–antitoxin module HipAB. The
toxin HipA is a Ser/Thr kinase that phosphorylates
and inactivates the glutamyl-tRNA synthetase GltX.
This leads to an increased pool of uncharged tRNAGlu,
which in turn leads to activation of the stringent
response and inhibition of cell growth (Fig. 1D) [109].
Dormancy is also a key feature of M. tuberculosis infec-
tion. After the primary infection, immune-derived gran-
uloma structures can form in which bacteria can reside
for decades. Inside the granuloma, M. tuberculosis faces
a hypoxic and nutrition-limited environment that leads
to development of dormant cells. The TCS DosSR con-
stitutes the main regulator of dormancy and is acti-
vated in response to hypoxia [110]. Thr
phosphorylation of the response regulator DosR by the
PknH kinase enhances DosR DNA binding and thus
expression from the dormancy regulon [111]. The
M. tuberculosis PknG kinase is similarly important for
persistence. Indeed, PknG is required for metabolic
adaptation to hypoxia and effective survival during
latency-like conditions, a role that is mediated via its
phosphorylation of the central metabolic regulator
GarA [112].
In summary, the above examples demonstrate the
importance of studying Ser/Thr/Tyr phosphorylation
in order to understand how pathogenic bacteria
invade, survive, and persist within their hosts. As
shown, bacterial kinases can modify numerous and
diverse proteins important for bacterial growth and
pathogenicity. The secretion of bacterial effectors that
can directly interfere with host phosphorylation signal-
ing furthermore expands the repertoire of phosphory-
lation-dependent mechanisms driving bacterial
infections. Notably, several of the discussed functional
studies were inspired from phosphoproteomic datasets,
emphasizing how unbiased phosphoproteomic profiling
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can be used to acquire novel insight into the regulation
of bacterial pathogenesis.
Phosphoproteomics in the study of
bacterial pathogenesis
Major advancements in MS-based proteomic method-
ologies over the last two decades have allowed
researchers to obtain global and unbiased insight into
protein PTMs at the site-specific level. Consequently,
it has revolutionized our knowledge of proteins and
their regulation. Nowadays, phosphoproteomics is a
mainstream laboratory technique used to identify regu-
latory events in all kinds of organisms. Mainly Ser/
Thr/Tyr-type phosphorylations have been extensively
studied in proteomic experiments. This is due to the
chemical lability of other types of phospho-bonds,
which challenge their detection by typical MS-based
protocols. Initially, phosphoproteomic protocols were
based on the separation of proteins on 2D gels where
excised phosphorylated proteins were analyzed by
MALDI-TOF MS. However, this strategy is biased
toward only the most abundant phosphoproteins and
can usually not determine the specific modification
sites. Thus, it was not until the development of gel-free
methods coupled to high-accuracy MS that high-
throughput and site-specific phosphoproteomic analy-
sis became feasible. The current state and future direc-
tions of phosphoproteomics in the study of bacterial
pathogens will be discussed below.
Large-scale identification of phosphosites
A typical shotgun phosphoproteomic experiment
involves the digestion of total cellular proteins fol-
lowed by liquid chromatography–tandem MS analysis
(LC-MS/MS) analysis of sorted phosphorylated pep-
tides. As phosphorylations are typically substoichio-
metric and of low abundance, phosphopeptides only
represent a tiny fraction of total protein digests [113].
Therefore, their isolation from the rest of the pro-
teome prior to MS analysis is of paramount impor-
tance for their successful detection [114,115]. The most
common enrichment methods are immobilized metal
affinity chromatography (IMAC) and metal oxide
affinity chromatography (most often with TiO2) [116].
Both methods rely on the affinity of negatively charged
phosphate groups for metals. Strong cation exchange
chromatography can furthermore be used to fraction-
ate peptides prior to phosphoenrichment to reduce
sample complexity and thereby improve phosphopep-
tide MS/MS identifications. Alternatively, phospho-
peptides can be enriched by phospho-specific
antibodies [115]. Another important step for maximiz-
ing phosphopeptide/site coverage is related to the frag-
mentation patterns of phosphopeptides during MS/
MS. Current fragmentation methods have recently
been discussed by Potel et al. [117]. Phosphoproteomic
protocols have primarily been developed for eukarya,
for which they are routinely used to identify tens of
thousands of sites [118,119]. Comparatively, bacterial
phosphoproteomes are much less explored. Bacterial
Ser/Thr/Tyr phosphosites are generally of a much
lower abundance compared to eukaryal sites
[113,120,121], making their identification more chal-
lenging. Nevertheless, since the first studies in bacterial
site-specific phosphoproteomics [122], our knowledge
of bacterial phosphoproteomes has greatly expanded
[2,114,123]. Phosphoproteomic studies in various types
of bacteria have revealed that phosphorylation affects
both basic bacterial physiology, such as central meta-
bolism and gene expression, as well as more pathogen-
specific functions [63,64,124–136]. A high proportion
of studies have been conducted for M. tuberculosis,
likely reflecting the high prevalence and mortality rates
of disease caused by this organism [137,138]. Together,
Tables 2 and 3 provide an overview of the untargeted
and gel-free Ser/Thr/Tyr phosphoproteomic studies
performed in pathogenic bacteria to date. While initial
studies generally identified in the range of 50–500
phosphosites from several mg of starting protein (de-
pending on the species), significant improvements in
sample preparation have more recently been reported.
For example, it is seen that the removal of interfering
bacterial biomolecules, such as phospholipids, peptido-
glycans, and nucleic acids, prior to phosphopeptide
enrichment, can greatly increase phosphosite identifica-
tions [139–142]. Potel et al. [140] incorporated ben-
zonase treatment and protein precipitation by
methanol/chloroform in their workflow to obtain
ultrapure phosphopeptide samples from which they
identified 10 times as many E. coli phosphosites com-
pared to a standard protocol. Another method that
enhances sample purity is the prepurification of phos-
phopeptides by calcium phosphate precipitation (CPP)
[143]. CPP treatment significantly expanded phospho-
site coverage for the nonpathogenic Strepto-
myces coelicolor [142]. Improved phosphopeptide
recovery may also be obtained by using IMAC resins
in a column format rather than batch or microtip
enrichment [140,144]. Moreover, species-specific opti-
mization may be required to maximize protocol effi-
ciencies [139].
The recent acquisition of large bacterial phospho-
proteomes has allowed the assessment of phosphosite
sequence features, representing putative kinase
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recognition motifs. Phosphorylation consensus
sequences have been identified in datasets obtained
from M. tuberculosis [51,125], Helicobacter pylori
[145], S. flexneri [64], and E. coli [63,146,147], includ-
ing bacteria-specific N- and C-terminal phosphoryla-
tion preferences [139,147]. Interestingly, a
phosphoproteomic dataset from the tick-transmitted
Ehrlichia ruminantium pathogen was enriched in recog-
nition motifs for several eukaryal kinases, suggesting
significant host cell interaction [148]. Another general
theme of bacterial phosphoproteomes is that they, sim-
ilar to the eukaryal ones, are dominated by pSer sites,
followed by pThr and, to a lesser extent, pTyr modifi-
cations. One exception is M. tuberculosis where pThr
sites are more frequently reported [149–151]. However,
pTyr sites are likely underrepresented in phosphopro-
teomic datasets obtained with metal affinity chro-
matography as their relatively low abundance
compared to pSer and pThr sites can result in their
disproportional enrichment. Instead, antibody-based
pTyr-peptide isolation strategies can greatly improve
pTyr identifications [115] with approximately 500 and
1000 pTyr sites identified in E. coli and S. flexneri,
respectively [63,64]. An alternative strategy may be to
use pTyr-binding SH2-peptide domains as a pTyr
affinity reagent [152]. As the collection of bacterial
phosphoproteomes continues to expand, it will allow
more systematic analyses of phosphosite features
across different species, potentially revealing interest-
ing differences between pathogens and nonpathogens.
To facilitate comparative and functional studies of
bacterial phosphorylation, phosphosite data should be
easily retrievable from public databases dedicated to
collecting experimentally verified phosphosites. Yet
such resources are currently underdeveloped for bacte-
ria compared to eukarya. Curated databases that do
include bacterial phosphosites are PHOSIDA, dbPTM,
and the bacteria-specific dbPSP [153]. These were
recently reviewed by Pagano et al. [154].
Assaying phosphoproteome dynamics
To obtain more than mere snapshots of cellular
phosphoproteomes, phosphoproteomic workflows
must be coupled to quantitative methods. Only then
can the dynamics of phosphorylation events, and
thus their regulatory implications, be understood.
Quantification can be obtained either with labeled or
nonlabeled approaches. Labeling techniques can be
either metabolic, such as stable isotope labeling of
amino acids in cell culture (SILAC), or chemical; for
example, isobaric tag for relative and absolute quan-
titation, tandem mass tag (TMT) or dimethyl peptide
labeling [155,156]. The disadvantages of using label-
ing are that only a limited number of labels can be
used simultaneously and, thus, the number of sam-
ples that can be compared is restricted. However,
several labeled experiments can be combined via a
common sample to obtain relative quantification
comparing an increased number of samples. For
instance, two triple-SILAC experiments were com-
bined to record phosphorylation dynamics during
E. coli culture growth [121]. Importantly, quantitative
methods can be used to investigate infection-related
phosphorylation. Verma et al. [125], for example,
used a TMT-based quantitative approach to identify
phosphorylation events specific to M. tuberculosis vir-
ulence by comparing virulent and attenuated sub-
strains. Similarly, Marcelino et al. [148] used label-
free quantification to compare the phosphorylation
patterns of virulent versus attenuated variants of
E. ruminantium that had been grown together with
bovine aortic endothelial cells. Misra et al. used a
hypervirulent strain of Listeria monocytogenes, har-
boring an activating mutation in the virulence gene
activator PrfA, to identify virulence-associated phos-
phorylation events. This approach found the phos-
phorylation of especially glycolytic enzymes to be
upregulated in the hypervirulent strain compared to
a nonvirulent control; findings that are in line with
altered glycolytic activity of L. monocytogenes during
intracellular growth [157]. Finally, the phosphopro-
teome of a subspecies of Francisella tularensis (the
causative agent of ‘rabbit fever’) was profiled in
response to KCl, which induces T6SS formation
required for immune evasion. Together with func-
tional experiments, this study was able to establish
Tyr phosphorylation of a T6SS sheath component to
be essential for T6SS biogenesis [158]. Quantitative
phosphoproteomics can also shed light on mecha-
nisms of antibacterial drug resistance. For E. coli,
label-free quantification was used to compare a clini-
cally isolated antibiotic-resistant strain with wild-type
cells grown with or without antibiotics for several
time periods. This uncovered numerous cases of
phosphorylation events potentially driving antibiotic
resistance, such as on transcription factors that regu-
late resistance [147]. Another study aimed to under-
stand the phenotypic mechanisms that contribute to
M. tuberculosis tolerance to the first-line antibiotic
rifampicin. By examining phosphoproteome dynamics
of the Beijing strain B0/W148 in response to high-
dose rifampicin, the authors identified upregulated
phosphorylation of proteins involved in iron seques-
tration, which is believed to be linked to antibiotic
resistance and dormancy [151].
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Table 2. Table listing gel-free and site-specific shotgun phosphoproteomic studies performed in pathogenic bacteria. Quantitative studies




Acinetobacter baumannii (reference and invasive
multidrug-resistant strains)
No Strain ATCC17978: 48/41 Strain
Abh12O-A2: 80/70
2014 [126]
Acinetobacter baumannii (clinical imipenem-
resistant and sensitive strains)
No Strain SK17-S: 410/248
Strain SK17-R: 285/211
2016 [124]
Escherichia coli No 81/79 2008 [189]
Escherichia coli Yes (Growth phase analysis) 108 2013 [121]
Escherichia coli No 766/392 2015 [139]
Escherichia coli Yes (Antibiotic treatment and
resistance)
2509/1133 2018 [147]
Escherichia coli Yes (Growth phase analysis) 1883 sites 2018 [141]
Escherichia coli No >1600 sites 2018 [140]
Escherichia coli No 512/342 (pTyr only) 2013 [63]
Ehrlichia ruminantium Yes (Comparing virulent and
attenuated strains)
92/58 2019 [148]
Francisella novicida Yes (KCl treatment) 103 phosphopeptides 2019 [158]
Helicobacter pylori No 126/67 2011 [127]
Helicobacter pylori No Strain OK145: 50 sites Strain
TN2GF4: 50 sites
2019 [145]
Klebsiella pneumoniae No 93/81 2009 [128]
Klebsiella pneumoniae No 559/286 2015 [139]
Leptospira interrogans No 27 sites 2010 [129]
Listeria monocytogenes No 143/112 2011 [130]
Listeria monocytogenes Yes (PrfA WT versus PrfA*
activated mutant strain)
242/191 2014 [157]
Mycobacterium tuberculosis No 516/301 2010 [131]
Mycobacterium tuberculosis No 414/214 2015 [132]
Mycobacterium tuberculosis Yes (Antibiotic treatment) 191/132 2016 [151]
Mycobacterium tuberculosis Yes (Comparing virulent and
attenuated strains)
512/257 2017 [125]
Mycobacterium tuberculosis No 30/17 (pTyr only) 2014 [21]
Pseudomonas aeruginosa No 59/28 2014 [133]
Pseudomonas aeruginosa No 55 sites 2009 [134]
Staphylococcus aureus No 76/108 2014 [135]
Shigella flexneri No 905/573 (pTyr only) 2016 [64]
Streptococcus pneumoniae No 163/84 2009 [136]
Table 3. Table listing phosphoproteomic studies aiming at identifying kinase substrates in pathogenic bacteria. The table provides
information on the quantitative method used and on the numbers of potential kinase substrates as well as total phosphosites/










SILAC Not easily extractable 1183/632 [146]
Mycobacterium tuberculosis PknB TMT peptide
labeling
111/73 390 phosphopeptides /258 [150]
Mycobacterium tuberculosis PknB Label-free 17/13 ND [48]
Mycobacterium tuberculosis PknA/B Label-free 68/48 1241/470 [51]
Streptococcus agalactiae Stk1 Not quantitative 10/10 ND [160]
Vibrio alginolyticus PpkA2 Not quantitative 10/8 ND [76]
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Assigning substrates to kinases
To fully understand individual phosphorylation events,
as well as entire phosphorylation networks, we need to
characterize their regulation by kinases and phos-
phatases. Currently, only very few kinase–substrate
pairs have been defined. By analyzing strains with
altered levels of kinase activity, quantitative phospho-
proteomics can identify phosphorylation events depend-
ing on a kinase of interest. Several groups have used
this strategy to elucidate the substrates of Ser/Thr
kinases in pathogens (see Table 3) [76,159,160]. For
example, to shed light on the mechanisms behind HipA
kinase-dependent E. coli persistence, HipA and its vari-
ant HipA7 were overproduced from ectopic promoters
and their substrates sought out by SILAC experiments
[146]. Though, the success of such a strategy will
depend on the mechanism of kinase activation as kinase
overexpression may not by itself upregulate kinase
activity if the activating signal is concomitantly low. To
identify substrates of the essential M. tuberculosis PknB
kinase, Kaur et al. used a hyperactive mutant version
(PknB-GM). This allowed them to identify 73 potential
PknB substrates hyperphosphorylated in the PknB-GM
background [150]. Another strategy in the search for
M. tuberculosis PknB substrates was applied by Tura-
pov et al. They used a conditional deleterious PknB
mutant that could successfully grow in a specialized
osmoprotective media. Label-free quantitative compar-
ison of PknB-producing and PknB-depleted cells
detected 13 potential PknB substrates, of which the pep-
tidoglycan amidase homolog CwlM was characterized
by further analysis [48]. An alternative to genetic
manipulation is the use of chemical kinase inhibitors. A
small-molecule inhibitor targeting both PknA and PknB
was, for example, used by Carette et al. [51] to uncover
M. tuberculosis PknA/B substrates by label-free quan-
tification. Notably, among the 68 potential substrates
identified in the Carette study, only nine overlap with
the Kaur et al. dataset, and an overlap of only one and
two substrates is seen for each of these studies with
Turapov et al., respectively. As this is likely to reflect
the fact that dissimilar experimental conditions will
reveal different substrate subpools, it highlights the
need for extended and multifaceted screening to fully
elucidate the substrate repertoire of any given kinase.
Even though the above-mentioned studies are clearly
invaluable in helping to suggest kinase substrate candi-
dates, precautions must be made in their interpretation.
More specifically, one must dissect phosphorylation
events directly mediated by an investigated kinase from
those mediated by downstream kinases operating within
the same signaling cascade. Furthermore, kinases form
highly interconnected networks and perturbation of a
single kinase is therefore likely to also influence other
signaling nodes [1,161]. When using chemical inhibitors,
one should additionally be aware of unspecific effects
occurring due to off-target inhibitor binding. Therefore,
complementary cross-validation such as by in vitro
kinase or co-immunoprecipitation assays is essential to
sort out direct from indirect targets.
Host–pathogen interactions at the
phosphoproteome level
Knowledge of the molecular interactions that occur
between pathogens and their hosts is critical not only
for understanding the course of infectious diseases but
also for discovering novel targets for future antibacte-
rial therapies. A significant amount of host–pathogen
crosstalk involves their PTMs. In addition to indirect
effects exerted by pathogens on host phosphopro-
teomes via the activation of immune and stress
responses, bacteria may, as described earlier, also
interfere with host phosphorylation signaling in very
direct ways. They may, for example, secrete effector
kinases and phosphatases able to target host proteins,
or they may interact with host phosphoproteomes via
a family of phospho-binding domains present in both
host and some bacterial cells [79,97,98]. The use of
quantitative phosphoproteomics has become instru-
mental for elucidating pathogen-induced phosphoryla-
tion signaling in host cells. For example, the effect of
the Salmonella pathogenicity island 2 (SPI2) on host
phosphorylation was assessed in infected macrophage
and epithelial cells by SILAC experiments [162]. SPI2
encodes a T3SS responsible for secreting a high num-
ber of virulent factors, including the Salmonella Hanks
kinase SteC. Additional quantitative phosphopro-
teomic profiling of SteC-transfected host cells, in com-
bination with an MS-based SteC binding partner
screen, identified the Hsp27 host protein as a direct
SteC substrate through which SteC induces actin
cytoskeleton remodeling to promote Salmonella intra-
cellular growth [162]. Pathogen-induced phosphopro-
teome alterations have also been investigated for
H. pylori-infected human gastric epithelial cells
[163,164]. Notably, temporal pTyr-specific phospho-
proteomics revealed that changes in host phosphoryla-
tion mainly occurred at the early stages of infection
compared to a 7-h postinfection time point. To further
identify host signaling pathways affected by H. pylori
infection, a wild-type strain was compared to mutant
strains deleted for components of the cag pathogenic-
ity island. This approach allowed dissection of host
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signaling responses depending on the entire T4SS
secretion system and the T4SS effector protein Cag4,
respectively. While T4SS induced JNK and p38 kinase
activation, Cag4 was required for ERK1 signaling
[164]. Using a similar experimental design, time-specific
phosphorylation was assessed for human cells infected
with either wild-type or mutant enteropathogenic
E. coli (EPEC) deficient for the virulence-associated
T3SS secretion system [165]. This screen revealed acti-
vation of host mitogen-activated protein kinase
(MAPK) signaling by EPEC infection and identified
various T3SS-dependent phosphorylation events asso-
ciated especially with immune responses, intracellular
trafficking, and cytoskeletal regulation. Importantly,
this study provided novel mechanistic insight into
EPEC pathogenesis by identifying T3SS-mediated
phosphorylation of the septin-9 protein to be critical
for efficient EPEC–host cell adherence [165]. A study
on F. tularensis also pointed to host MAPK signaling
being disturbed upon pathogen interaction. Fabrik
et al. used SILAC-based quantification to analyze the
temporal dynamics of phosphorylation in primary den-
dritic cells (DC) at the early stages of infection by
either virulent or attenuated F. tularensis versions.
They found that the DC phosphorylation response
underwent distinct phases, which differed between the
two strains. Only the virulent strain induced later-
phase MAPK signaling, believed to facilitate host sur-
vival and immune suppression [166].
Increasing the comprehensiveness of
phosphoproteomic datasets
Despite significant recent progress in bacterial phos-
phoproteomics, as described above, there is still a long
way to go before we have fully elucidated the complex-
ity of pathogen phosphorylation networks. Optimizing
phosphoproteomic protocols is essential if we are to
obtain a deep and global understanding of the phos-
pho-regulatory events that drive infectious diseases.
For instance, to identify infection-relevant phosphory-
lation sites, phosphoproteomic analysis should be per-
formed for bacteria isolated from in vivo infections.
While experiments performed with free-living cells
have shed important light on modification patterns
under different growth and virulence conditions, phos-
phorylation sites should be recorded during live infec-
tions to increase the chance of identifying substrates
important for pathogenesis. This could include either
infected cell lines or mouse models [167]. Temporal
changes in pathogen phosphoproteomes should then
be systematically recorded over the course of the infec-
tion process. Separation of subcellular structures
would further allow for a spatial resolution of phos-
phoproteome dynamics [168]. Moreover, parallel anal-
ysis of samples obtained from the infected host would
allow one to correlate bacterial and host phosphoryla-
tion patterns and obtain integrated insight into host–
pathogen interactions. We propose that continued
improvements in sample preparation, quantification
methods, MS instrumentation, and data processing
should make such experiments possible. A major chal-
lenge is associated with enriching low-abundance phos-
phopeptides from already low quantities of material
obtainable from in vivo infection models. As bacterial
proteins will be highly diluted in the more complex
host proteome, the separation of bacteria from host
cells must be optimized [169]. Continued developments
in phosphopeptide preparation [139,140,141] and MS
instrumentation [170] will further help to maximize the
phosphosite coverage that can be obtained from these
samples. Emergence of streamlined and time-effective
sample preparation platforms that reduce sample
requirements and optimize sample reproducibility [171]
should in particular spur the generation of large-scale
bacterial phosphoproteomic studies that require the
parallel analysis of a high number of samples. Ideally,
workflows should be fully automated to allow rapid
and robust high-throughput sample processing. To this
end, Leutert et al. [172] recently developed an end-to-
end automated phosphoproteomic protocol (rapid-
robotic phosphoproteomics or R2–P2) where proteins
and phosphopeptides are captured on magnetic beads
and processed in 96-well plates using a magnetic parti-
cle-processing robot.
The basis for obtaining meaningful biological
information from phosphoproteomic datasets is the
reproducible quantification of phosphopeptides. Phos-
phoproteomic quantification methods have tradition-
ally involved labeling due to reproducibility problems
of label-free methods where individual sample process-
ing leads to high sample-to-sample variation. Even
though SILAC is considered the most accurate quan-
tification method [173] it is not suitable in cases where
a high number of samples are to be compared, such as
in extended time series experiments, or in cases where
metabolic labeling is not feasible. Instead, multiplexing
by TMT peptide labeling now allows comparative
analysis of up to 11 samples and label-free quantifica-
tion allows the comparison of an essentially unlimited
number of samples. Furthermore, recent innovations
in label-free methodologies have greatly justified their
usage [174,175]. A detailed comparison of common
phosphoproteomic quantification methods was recently
produced by Hogrebe et al. [173]. Their conclusion
was that even though label-free quantification and
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SILAC are the most accurate techniques, MS2-based
TMT-based quantification is at present the best
method for identifying biologically meaningful regula-
tory phosphorylation events.
Another source for improving bacterial phosphopro-
teomics comes from advances in MS acquisition meth-
ods. New data-independent acquisition (DIA) setups can
boost both the depth and reproducibility of shotgun
proteomic analysis [167,170,176,177]. Compared to tra-
ditional data-dependent acquisition (DDA), where only
the most abundant peptide ions in MS1 are selected for
MS2 fragmentation in a semi-stochastic manner, all pep-
tides within a predefined m/z range are cofragmented
and measured together in DIA mode. This way DIA
enables systematic measurement of all peptide ions
including very low-intensity/abundance peptides. Better
performance in terms of reproducibility and accuracy
also makes DIA highly suitable for quantification pur-
poses. Though, due to the high complexity of MS2 spec-
tra resulting from peptide cofragmentation, DIA holds
several analytical challenges and requires sophisticated
processing tools. Typical spectral deconvolution methods
rely on prerecorded spectral libraries but more stream-
lined methods based on in silico libraries or neural net-
works are now on the rise [178–180]. Although DIA has
not yet been adapted to bacterial phosphoproteomics,
an optimized DIA-based quantitative phosphoproteomic
protocol was recently reported for human cells [177].
Using label-free quantification, the authors were able to
quantify more than 10 000 phosphorylation sites across
hundreds of samples. Other acquisition settings that
avoid the random sampling problems of DDA are tar-
geted approaches such as selected reaction monitoring
(SRM) and parallel reaction monitoring (PRM) [181].
PRM and SRM are highly suitable for experiments that
seek sensitive and reproducible analysis of already pre-
specified phosphopeptides [182]. In summary, the field
of phosphoproteomics is still undergoing profound
advancements. The constant advent of methodologies
improving the sensitivity, robustness, and quantification
of phosphoproteomic profiling will undoubtedly expand
our insight into infection-related signaling from both the
host and pathogen perspective. Eventually, optimized
protocols will allow us to chart pathogen phosphoryla-
tion signatures from a minimum of material, such as
from infected patient samples, to suggest biomarkers for
precision medicine of the future.
Making sense of phosphoproteomic
data
While MS-based studies produce large lists of phos-
phorylated amino acids, characterizing the function of
each of these sites can so far not be performed in a
high-throughput manner and thus represent a major
bottleneck in phosphoproteomic research. This is, for
example, reflected in the fact that less than 3% of
identified human phosphosites have been designated a
function [1]. In this section, we will present emerging
concepts and methods, primarily arising from the
study of eukaryal phosphoproteomes, that can propel
the functional interpretation of phosphosites and phos-
phorylation networks at a global scale. Furthermore,
the integration of phosphoproteomics with other types
of omics data should eventually allow us to obtain a
more holistic view of infectious diseases.
Functional prioritization of phosphosites
Addressing ways to predict functionally relevant phos-
phosites from big datasets has become a key point in
phosphoproteomics as it allows researchers to priori-
tize phosphosites for further experimental exploration.
Such prioritization is especially important given the
suggestion that a noticeable proportion of phospho-
sites may be nonfunctional and possibly occur due to
random kinase encounters and/or evolutionary neutral
drift in regulatory interactions [183–185]. Exhaustive
examinations of eukaryal phosphoproteomes have sug-
gested that features such as phosphosite stoichiometry,
condition-dependent dynamics, evolutionary conserva-
tion, PTM colocalization, and structural context can
be used to indicate phosphosite functional relevance
[1,185,186]. For instance, a large fractional stoichiome-
try is a good indication of phosphosite importance
[119,187]. Though, the opposite is not always true as
low-stoichiometry sites might mediate specialized func-
tions for a minor subpool of a protein. Methods to
systematically determine phosphosite stoichiometry
from large-scale studies are becoming increasingly
accessible [118,119,177].
Phosphosites are generally only slightly more con-
served than their nonmodified counterparts, a theme
seen for both eukarya and bacteria [63,183,185,188,189].
However, phosphosites with a known or predicted func-
tion show higher conservation rates [185,188]. More-
over, although phosphorylation might not be well
conserved at an exact position, it may be conserved
when considering a somewhat broader positional win-
dow. In fact, conserved so-called phosphorylation hot-
spots consisting of positionally less-constrained
phosphosites can indicate areas of regulatory potential
[185,190]. Eukaryal phosphosites are predominantly
found in disordered regions [191] and phosphorylation
hotspots situated herein are likely to regulate protein–
protein interactions [1,190]. Hotspot regions are also
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common in structural domains. By mapping known
phosphosites from 40 eukaryal species onto Pfam
domains, Strumillo et al. [186] identified 241 phosphory-
lation hotspots within 162 diverse domain families. Plot-
ting these regions onto structural data exposed that they
were often positioned at protein interfaces or nearby
catalytic residues, consistent with phosphorylation regu-
lating protein–protein contact and enzyme activity. In
line with the notion that integrating multiple sources of
information provides better predictive power compared
to single features, computational machine-learning
methods have recently been developed, as will be dis-
cussed later on, to systematically integrate multiple
phosphosite attributes in the assessment of phosphosite
function.
Because the above-mentioned structural and evolu-
tionary patterns of phosphorylation have been
extracted from eukaryal phosphoproteomes, they may
not necessarily apply to bacteria. Similar comprehen-
sive evolutionary analysis of bacterial phosphosites has
so far not been performed due to the relative scarcity
in recorded bacterial phosphoproteomes, but should
become possible as we accumulate more and better-
coverage datasets. In any case, the integration of phos-
phoproteomic data with structural information should
be highly instructive for predicting the specific func-
tional roles for bacterial phosphosites as well. In par-
ticular, the visualization of sites in their 3D
environment can reveal phosphosites that are physi-
cally close to functional protein regions in 3D even
though they are far in sequence. By suggesting regula-
tory potentials of phosphosites not deducible from
sequence analysis alone, structural insight can greatly
improve hypothesis-driven functional experiments. As
manual mapping of phosphosites onto protein struc-
tures is a time-consuming process, some online PTM
databases have started incorporating PDB (Protein
Data Bank) structural information into their user
interfaces [192]. A software tool to identify PTMs
stored in 3D PDB structures has also been developed
[193]. Recently a comprehensive PTM-structural data-
base was launched (PRISMOID accessible through
http://prismoid.erc.monash.edu/) in which protein
modifications extracted from six different databases
have been annotated onto matching PDB structures
[194]. Since bacterial phosphosites are still underrepre-
sented in Web-based repositories [154], their represen-
tation in PRISMOID is also minor. The shortage of
adequately solved structures further compromises
phosphosite 3D annotations. This notwithstanding, we
propose that the next step will be to develop software
that can integrate phosphosite-structural information
with phosphoproteomic datasets in an automated
manner. By integrating information from different
databases and prediction tools, the structural context
of individual phosphosites, for example, disorder,
domain, and interaction properties, could be extracted
at a global scale. Additionally, phosphosites could be
automatically mapped onto 3D structures if these are
available and visual depictions could be generated. In
cases where there is no structural data, it would be
highly desirable if, in the future, protein structural pre-
diction tools could alternatively provide some putative
structural context [195].
How can phosphoproteomics benefit from
machine learning
Machine learning is being increasingly used to make
sense of the high-throughput and complex datasets
produced in the ‘big data’ era. In short, machine learn-
ing is a type of artificial intelligence in which computer
systems are set to learn and improve upon their own
procedures through training datasets. Deep learning is
a next-generation branch of machine learning based
on multilayered neural networks and is best suited for
analyzing highly dimensional and structured data
available in very large quantities [196]. In the biologi-
cal sciences, machine-learning methods can be used to
identify cellular and molecular patterns embedded in
the noise of biological systems [197,198]. In the field of
phosphoproteomics, machine learning has especially
been used for identifying contextual features of experi-
mentally validated phosphosites with the aim to be
able to predict unknown sites from protein sequences.
Numerous different prediction methods have been
published, including some that focus on kinase-specific
phosphorylation sites [199,200]. A few prediction tools
have been specifically tailored to bacteria [201–203].
The first bacteria-specific phosphosite predictor, Net-
PhosBac, was developed using neural network algo-
rithms [201]. At that time though, only about 150
bacterial phosphosites, from just two species, were
available as a training dataset. The MPSite web
resource is a more recent and improved machine-learn-
ing predictor trained on more than 3000 unique bacte-
rial pSer and pThr sites from the dbPSP database
[153,203]. While these and most other methods are
solely based on primary, and maybe secondary, struc-
tural features, a small predictive performance gain
may be obtained by including phosphosite 3D-context
information [204]. Importantly, the use of deep-learn-
ing strategies particularly shows great promise for
improving phosphosite predictions. In contrast to con-
ventional machine-learning methods, which involve
manual feature selection, deep-learning algorithms
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allow automatic and unbiased discovery of phosphory-
lation patterns [205,206]. Owing to their improving
performances, in silico predictions represent a valuable
supplement to experimental phosphosite identification
methods. For instance, in addition to being relatively
labor- and resource-intensive, MS-based phosphopro-
teomic protocols also pose noteworthy technical limi-
tations. In particular, they allow the identification of
only a limited number of sites in any given experiment,
that is, the sites modified to detectable degrees in the
specific cellular condition. On top of that, the usage of
just a few different amino acid-specific proteases (pre-
dominantly trypsin) in sample preparations, results in
fractions of phosphopeptides that are either too short
or too long for MS detection. This means that a signif-
icant portion of sites may persistently go undetected.
For these reasons, the continued development of
highly reliable phosphosite prediction algorisms could
make a crucial contribution to mapping all possible
phosphorylation substrates.
Another relevant application of machine learning is
in functional prioritization of phosphosites, as it enables
integrated evaluation of multiple distinct features that
can predict functionality [207]. This was indeed show-
cased by Ochoa et al. who incorporated 59 phosphosite
characteristics into a single functional score by training
machine-learning algorithms on human phosphosites of
already known function. Substantiating the applicability
of their model, it was able to correctly categorize regula-
tory phosphosites from a comprehensive reference
human phosphoproteome [208].
Finally, it is worth mentioning an example in which
machine learning was used to facilitate the challenging
task of identifying bona fide kinase substrates from
in vivo studies [209]. As described earlier, quantitative
phosphoproteomic screens are often used to elucidate
kinase–substrate pairs by comparing kinase-pertubated
cells with unpertubated cells. The interpretation of such
datasets is however hampered by the fact that manipula-
tion of a single kinase will alter the phosphorylation of
both direct and indirect substrates. To address this
issue, Kanshin et al. devised a machine-learning model
that could dissect direct from indirect substrates from a
large-scale quantitative phosphoproteomic experiment
involving kinase inhibition. As a list of already known
substrates was not available to use as a training set for
conventional machine learning, they applied an
approach related to positive and unlabeled learning.
Interestingly, their model, which was validated for two
different yeast kinases, found that direct kinase sub-
strates display higher fold changes and faster dephos-
phorylation kinetics upon kinase inhibition compared
to indirect substrates [209].
‘Omics’ data integration toward a
systems-level understanding of infection
While phosphoproteomics can offer important insight
into protein post-translational regulation, it only offers
information on one aspect of a cell’s biological state.
In concert with massive developments within large-
scale molecular biology techniques, such as genomics,
transcriptomics, proteomics, and metabolomics, there
has been an increasing interest in integrating different
types of ‘omics’ data to explore bacterial physiology
and pathogenicity in a more systemic manner
[210,211]. Current studies include integration of two or
more ‘omic’ layers. Deatherage Kaiser et al., for exam-
ple, used a multi-omics strategy that combined pro-
teomics, metabolomics, glycomics, and metagenomics
to elucidate interactions occurring between Sal-
monella enterica, its murine host, and the intestinal
microbiome, revealing the capability of S. enterica to
alter gut microbiome composition for its own advan-
tage [212]. Ramos et al. [213] integrated genomic, tran-
scriptomic, metabolic, and protein structural
information to identify candidate targets for the devel-
opment of novel antibiotics in Klebsiella pneumoniae.
A few studies have included phosphoproteomic data in
their multi-omics approach. A comprehensive inte-
grated multi-omics dataset was prepared for
Mycoplasma pneumoniae, comprising data from phos-
phoproteomics, lysine acetylomics, DNA methylomics,
transcriptomics, proteomics, protein–protein interac-
tomics, metabolomics, and a genomewide essentiality
map [171,214]. Using this resource to explore the regu-
latory layers of protein abundance, Chen et al. [214]
uncovered that antisense noncoding RNAs, lysine
acetylation, and protein phosphorylation were all bet-
ter predictors of protein abundance than mRNA
levels. A different study used multi-omics profiling,
incorporating quantitative phosphoproteomics, pro-
teomics, transcriptomics, lipidomics, and metabolo-
mics, to achieve a deeper understanding of the
essential roles played by the PknA and PknB Hanks
kinases in M. tuberculosis pathogenicity. Together with
chemical PknA/B inhibition, this multisystem analysis
uncovered a role for PknA/B in the regulation of cell
envelope and protein secretion processes, proposedly
via phosphorylation of the essential TCS response reg-
ulator MtrA [51]. Similar integration of different omics
assays is also being used to elucidate bacterial patho-
genesis from the perspective of the host [211,215].
However, successful integration of heterogeneous mul-
ti-omics data under a mathematical model is still fac-
ing significant challenges. Differences in data file
formats, nomenclatures, dimensionality, and quality
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constitute some of the key obstacles for computational
data integration and call for community-wide data
standardization [216]. Further improvements in omics
data preprocessing, integration, and machine-learning
analysis are essentially needed to fully capitalize on the
huge amount of information embedded in large-scale
omics datasets. Looking ahead, multi-omics integra-
tion together with machine-learning modeling will
likely revolutionize our knowledge on bacterial patho-
genesis. In particular, integrating data obtained from
both host and bacteria should help to uncover the
complex web of molecular interactions that dictates
infectious outcomes and ultimately offer a systems-
level understanding of infectious diseases.
Phosphorylation in antibacterial
therapies
The continuous emergence and worldwide spreading of
drug-resistant bacterial strains [217] places a high
demand on discovery of new antibacterial compounds.
Understanding the molecular basis behind both inher-
ent and acquired drug resistance is evidently crucial to
devise such novel types of therapeutic strategies.
Increased awareness of the essential roles played by
bacterial kinases in the control of bacterial growth,
pathogenicity, and antibiotic resistance has led to their
exploration as potential future drug targets. Inspired
by drugs already used in the clinic to treat cancer,
there is an increasing effort to identify bacterial kinase
inhibitors that can obstruct key signaling pathways
sustaining bacterial pathogenesis and antimicrobial
resistance.
Phosphorylation in antibiotic resistance
Common mechanisms underlying antibiotic resistance
include modification or degradation of the antimicro-
bial agent to render it ineffective, modification of tar-
get proteins to reduce drug binding, and altered drug
influx/efflux. Several studies have found that antibiotic
resistance can be driven by bacterial kinases. Particu-
larly, transmembrane Hanks kinases with PASTA
domains are seen to confer resistance to cell-wall-in-
hibiting b-lactam-type antibiotics in various Gram-pos-
itive species [14,19,34,36,218–221]. Although this may
not be surprising given their role in cell division and
cell wall homeostasis as described earlier, the mecha-
nism(s) by which Hanks-type PASTA kinases promote
b-lactam resistance are only poorly defined. In
S. pneumoniae antibiotic-sensitive strains, including
some clinical isolates, the response to the b-lactam
drugs involves the StkP Hanks kinase and its cognate
phosphatase PhpP [218,222]. StkP and PhpP expres-
sion as well as StkP phosphorylation is induced upon
sublethal exposure to penicillin or cefotaxime. Deleting
PhpP augments StkP phosphorylation levels and con-
fers drug resistance, suggesting that StkP inactivation
could be a strategy for overcoming S. pneumoniae b-
lactam resistance [218]. Similarly, L. monocytogenes
PrkA, Enterococcus faecalis IreK, C. difficile PrkC,
and MRSA Stk1 are all required for resistance to dif-
ferent types of b-lactams [19,34,36,219–221]. In S. au-
reus, b-lactams induce the phosphorylation of the b-
lactam antibiotic-sensing protein BlaR1 and this initi-
ates a cascade leading to expression of antibiotic resis-
tance determinants [223]. In E. faecalis, b-lactams
stimulate IreK autophosphorylation, and this in turn
leads to phosphorylation of the TCS histidine kinase
CroS required for antibiotic resistance [224]. Staphylo-
coccus aureus Stk1 has also been linked to the resis-
tance to vancomycin, which is another type of cell
wall-acting antibiotic. More specifically, Stk1 was
shown to negatively regulate the DNA-binding activity
of the vancomycin-resistance-associated response regu-
lator VraR of the VraTSR three-component system
[225]. These latter two examples illustrate the sophisti-
cated crosstalk that occurs between different phospho-
rylation systems in the orchestration of drug
responses.
Other types of antibiotics work by interfering with
DNA replication, such as the quinolones. In M. tu-
berculosis, phosphorylation of the global transcrip-
tional regulator MgrA by PknB controls its
differential induction of the NorA and NorB mul-
tidrug-resistance efflux pumps, correlating with resis-
tance to different types of quinolone drugs [226].
Other M. tuberculosis Hanks kinases implicated in
drug resistance are PknF and PknG. In fact, the sol-
uble PknG kinase promotes natural resistance to a
broad diversity of antibiotics, including ones that tar-
get transcription, translation, and cell wall biosynthe-
sis [227], while PknF is believed to reduce the activity
of the antitubercular drug ethionamide [228]. Ethion-
amide is a prodrug that needs to be activated by the
monooxygenase EthA and EthA expression is regu-
lated by the transcriptional regulator EthR. Notably,
PknF phosphorylation of EthR negatively affects its
DNA-binding activity, and further studies should
determine how this affects M. tuberculosis ethion-
amide resistance [228].
Taken together, the above findings emphasize the
importance of phosphorylation signaling in bacterial
drug responses. Yet it is also clear that substantially
more work is needed to fully delineate the diversity of
molecular mechanisms behind kinase-dependent
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drug resistance. Such work will be instrumental in
developing new and efficient types of antimicrobials,
as discussed below.
Drugging bacterial kinases
Due to their well-documented and multifaceted roles in
pathogenesis and antibiotic resistance, bacterial kinases
are currently being investigated as potential new drug
targets. While drug discovery studies are also trying to
find targets toward histidine kinases [229], these will not
be the focus here. Small-molecule drugs that target
human Ser/Thr and Tyr kinases are already being rou-
tinely used in the treatment of several types of cancers
and new classes of human kinase inhibitors continue to
be experimentally and clinically explored [230]. The
majority of these drugs target the ATP binding pocket of
the kinase catalytic domain and given their clinical suc-
cess, it was suggested that similar compounds could be
devised against bacterial kinases. Already established
small-molecule kinase inhibitor libraries have accord-
ingly helped guide bacterial drug studies. Many efforts
have especially been made to pharmacologically target
the essential PknB kinase of M. tuberculosis [231–235].
For example, Lougheed et al. first screened a commercial
library of more than 50.000 compounds and then opti-
mized on a group of inhibitor candidates by medicinal
chemistry [233]. Chapman et al. [234] also performed
high-throughput screening followed by optimization of
an aminopyrimidine inhibitor. However, while these can-
didate drugs were very efficient in inhibiting PknB activ-
ity in vitro (in the nanomolar range), their potency
in vivo was only modest with minimum inhibitory con-
centrations in the micromolar range. This did not appear
to be due to poor cell wall permeability [233,234].
Another approach to identify kinase inhibitors is by
in silico modeling. Wlodarchak et al. [236] exploited the
general structural similarity of bacterial and human Ser/
Thr kinases to identify PknB inhibitors by in silico
screening of a human kinase inhibitor collection. Their
in silico structural docking revealed a family of imida-
zopyridine aminofurazan lead compounds with high
binding affinity toward PknB. Intriguingly, and consis-
tent with the known role of PknB in cell wall homeosta-
sis, these inhibitors were able to significantly potentiate
the effect of b-lactams in several types of mycobacteria
and in the related Nocardia asteroides [236]. This syner-
gistic concept has also been reported for kinase inhibi-
tors of the nonessential L. monocytogenes PrkA and
S. aureus Stk1 Hanks kinases [219,223,237–240]. In
L. monocytogenes, the broad-spectrum kinase inhibitor
staurosporine, as well as some more selective repur-
posed human kinase inhibitors, was seen to inhibit PrkA
activity and sensitize cells to b-lactam drugs [219,237].
Similarly, several studies have identified Stk1-inhibiting
molecules from small-molecule libraries that sensitize
MRSA S. aureus strains to b-lactams [223,238–240].
Notably, Kant et al. optimized a quinazoline-based
Stk1-inhibiting molecule (Inh2-B1) that potentiates the
bactericidal activity of the cephalosporins ceftriaxone
and cefotaxime on drug-resistant S. aureus, both
in vitro and in an in vivo septicemia mouse model with
negligible cytotoxic side effects [240]. Mechanistically,
Inh2-B1 was shown to reduce the expression of cell wall
hydrolase-encoding genes important for cell wall synthe-
sis and biofilm formation. This effect is likely to occur
due to reduced phosphorylation and promoter binding
of the WalR response regulator upon Stk1 inhibition
[240]. Thus, in summary, several observations suggest
that combined b-lactam and Hanks kinase inhibition
therapy could represent a novel strategy to combat clini-
cal b-lactam resistance.
Another line of currently investigated mycobacterial
inhibitors are targeted toward the cytosolic PknG kinase
[86,241,242]. In contrast to PknA and PknB, PknG is not
essential but is instead important for host intracellular
survival by blocking macrophage phago-lysosomal
fusion [86]. By only targeting intracellular mycobacteria,
it may be expected that PknG inhibition would pose less
selective pressure for the development of resistant strains
[243]. Encouragingly, an initial drug screen found that
chemical inhibition of PknG at its ATP-binding site
allowed effective macrophage clearing of mycobacterial
cells via the phago-lysosomal system [86,241]. Since
PknG is also proposed to be crucial for the survival of
mycobacterial dormant persisters, antitubercular combi-
nation therapies that include PknG inhibition could be a
prospective means to prevent disease reactivation
[112,243]. An extensive overview of presently investi-
gated mycobacterial kinase inhibitors is provided in
Khan et al. andMori et al. [243,244].
Even though the above-mentioned studies clearly
demonstrate the clinical potential of bacterial kinase
inhibitors, there are, to best of our knowledge, so far no
reports on Ser/Thr or Tyr kinase inhibitors displaying
promising antibacterial activities for single-drug clinical
use. Larger scale drug screening and optimization of
compound leads is basically needed to make antimicro-
bial kinase drugs clinically relevant. As, for example,
discussed in Pensinger et al. [14], differences in biochem-
ical and antibacterial efficacy of currently tested drugs
may be related to limited penetration across the bacte-
rial cell envelope, not allowing drugs to reach their cyto-
plasmic targets. Another explanation for the discrepancy
between in vitro and in vivo effects could be due to
in vitro kinase function not properly reflecting kinase
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activity in the bacterial setting where kinases may be
tethered to the membrane and other molecular interac-
tion partners are present. Thus, more knowledge of drug
uptake mechanisms and in vivo kinase function is
needed for optimized drug design. Moreover, to be clini-
cally relevant, new drugs should be highly selective
toward only bacterial kinases and not show cross-reac-
tivity with host enzymes. To improve target specificity
of an initially identified PknA/B inhibitor, Wang et al.
[245] produced compound–enzyme cocrystals and identi-
fied a pocket in the drug binding site of PknB that was
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Fig. 2. Block chart presenting proposed future pipeline for phosphoproteomics in the study of bacterial infections. (1) Phosphoproteome
dynamics should be studied during in vivo bacterial infections such as by cell culture or mouse models, and parallel analysis should ideally
be performed on bacterial and host samples to facilitate an integrated understanding of host–pathogen signaling crosstalk. Furthermore,
samples should be acquired at several time points during the course of infection to obtain time-resolved insight into phosphorylation
dynamics. Quantification may be achieved by metabolic protein labeling, chemical peptide labeling, or label-free approaches. (2) Bacterial
and host cells should be separated prior to species-specific lysis and protein extraction. In addition, subcellular and/or subpopulation
fractionation may be performed to obtain spatially resolved sample analysis. (3) Reproducible and time-efficient analysis of a high number of
parallel samples should be possible by automated procedures for phosphopeptide enrichment and cleanup in 96-well formats. (4) High-
performance LC-MS/MS analysis of purified phosphopeptides together with optimized data acquisition methods, for example, DIA, should
result in datasets of high phosphoproteome coverage and good quantitative reproducibility. (5) Phosphoproteomic data should subsequently
be subjected to diverse types of bioinformatic and machine-learning analyses to get a systemic view of phosphorylation networks and to
generate testable predictions of phosphosite functionality. (6) Finally, integration of phosphoproteomes with other types of omics data
obtained from the same infection model should be analyzed by machine-learning algorithms to reveal molecular signatures of bacterial
infections that could be therapeutically exploited.
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modify their compound to achieve a 100-fold selectivity
over mammalian kinases. As the structure of, for exam-
ple, mycobacterial Hanks kinase domains displays only
around 20–30% similarity to eukaryal kinases, there
may be several options for designing highly bacteria-
specific drugs [243,246]. Alternatively, inhibitors could be
directed toward other kinase regions such as the extracellu-
lar PASTA domains, whichwould circumvent the problem
of having to cross the cell envelope [14]. As PASTA
domains are highly divergent [247] and not present in
eukarya they might be suitable target candidates for drugs
with high species specificity. Likewise, BY-kinases could
be desirable future drug targets due to their absence in
eukarya [248]. In any case, a thorough understanding of
kinase structure and function as well as of the molecular
basis for inhibitor specificity should be key to guide further
development of both effective and species-specific drugs
that could reach the clinic.
It should also be mentioned that another currently
pursued antibacterial strategy involves the development
of inhibitors directed toward secreted bacterial tyrosine
phosphatases [249,250]. In addition, host-directed thera-
peutics targeting host kinases represent yet another excit-
ing branch of explored anti-infectious medicines [251].
Host-directed therapeutics may, for example, inhibit
pathogen-hijacked host pathways or work to boost host
immune defenses. Importantly, drugs with such activities
can be derived from already commercially approved
drugs, a concept known as drug repurposing [252].
Conclusions and perspectives
While individual phosphoprotein studies have provided
valuable information about the function of Ser/Thr/
Tyr phosphorylation in specific contexts, a more sys-
tematic view of phosphorylation landscapes and their
dynamics during different pathogenic stages is needed
to fully grasp the phospho-regulatory mechanisms
underlying bacterial pathogenesis. This includes the
acquisition of spatial and time-resolved datasets and
possibly, simultaneous analysis of both bacterial and
host phosphoproteomes to detect phosphorylation-de-
pendent host–pathogen interactions. In addition,
future developments of single-cell phosphoproteomics
will be useful for dissecting phosphorylation networks
in heterogeneous cell populations. A proposed pipeline
for future phosphoproteomic experiments in the study
of bacterial pathogenesis is provided in Fig. 2. Basi-
cally, we need to move from a discovery mode to a
quantification mode when it comes to studying bacte-
rial phosphorylation. Quantitative phosphoproteomics
techniques are routinely used to study phosphorylation
dynamics in eukarya. However, their application in
bacterial studies is lagging far behind and bacterial
phosphoproteomes remain in general largely under-
studied. This is partly due to detection difficulties
related to lower levels of protein phosphorylation
found in bacteria compared to eukarya. Thus, techni-
cal optimizations are urgently needed to achieve
desired insights into bacterial phosphoproteomes. DIA
MS represents one recent development that may bene-
fit bacterial proteomics as it allows reproducible detec-
tion of low-abundance peptides. This strategy has to
our knowledge not yet been applied in bacterial phos-
phoproteomics. Another major bottleneck in under-
standing the role of phosphorylation in bacterial
pathogenesis is the functional characterization of phos-
phosites generated from MS analysis. To help predict
phosphosite function, prediction strategies, relying on
evolutionary and structural information of the phospho-
site sequence, has been described for eukaryal phospho-
rylation. As we will gain more information on bacterial
phosphorylation, it will be interesting to see whether bac-
terial phosphosites conform to the same localization pat-
terns. We also argue that mapping of phosphosites onto
protein 3D structures, or known domains, should greatly
facilitate functional interpretations that can be tested
experimentally. We propose that such a contextualiza-
tion of sites generated from large screens should be auto-
mated in the future by the integration of phosphosite
datasets with structural databases or predictions. The
functional insights deriving from individual phosphory-
lation datasets could be enhanced by integrating them
with other omics data, such as transcriptomics, pro-
teomics, metabolomics, and acetylomics, to obtain a sys-
tems-level understanding of infectious diseases that can
guide future antibacterial therapies. Developments in
machine- and deep-learning algorithms are expected to
facilitate information extraction from complex multi-
omics data to unravel the contribution of protein phos-
phorylation to pathogenicity.
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